My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 248

    1.

    Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.

    Aung T, Oen FT, Wong HT, Chan YH, Khoo BK, Liu YP, Ho CL, See J, Thean LH, Viswanathan AC, Seah SK, Chew PT.

    Br J Ophthalmol. 2004 Jan;88(1):88-94.PMID: 14693782 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.

    Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW; Low-Pressure Glaucoma Study Group.

    Ophthalmology. 2005 Mar;112(3):376-85.PMID: 15745762 [PubMed - indexed for MEDLINE]Related articles

    3.

    Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II.

    Melamed S, David R.

    Clin Ther. 2000 Jan;22(1):103-11.PMID: 10688394 [PubMed - indexed for MEDLINE]Related articles

    4.

    The efficacy and safety of brimonidine 0.2% compared with timolol 0.5% in glaucoma: a randomized clinical trial on Taiwanese patients.

    Chen MJ, Chou JC, Hsu WM, Liu JH.

    J Chin Med Assoc. 2003 May;66(5):276-81.PMID: 12908569 [PubMed - indexed for MEDLINE]Related articles

    5.

    A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.

    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.

    Clin Ther. 2006 Apr;28(4):552-9.PMID: 16750466 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.

    Martínez A, Sánchez M.

    Clin Ther. 2008 Jun;30(6):1120-34.PMID: 18640468 [PubMed - indexed for MEDLINE]Related articles

    7.

    Acute primary angle closure: configuration of the drainage angle in the first year after laser peripheral iridotomy.

    Lim LS, Aung T, Husain R, Wu YJ, Gazzard G, Seah SK.

    Ophthalmology. 2004 Aug;111(8):1470-4.PMID: 15288973 [PubMed - indexed for MEDLINE]Related articles

    8.

    Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma : a prospective, randomized, controlled trial.

    Lam DS, Lai JS, Tham CC, Chua JK, Poon AS.

    Ophthalmology. 2002 Sep;109(9):1591-6.PMID: 12208703 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Drug therapy for residual angle-closure glaucoma after laser iridectomy]

    Wang N, Fan Z, Wu H, Li D, Huang Y, Chen J, Lin H.

    Zhonghua Yan Ke Za Zhi. 2002 Dec;38(12):712-6. Chinese. PMID: 12654218 [PubMed - indexed for MEDLINE]Related articles

    10.

    Iris ischaemic changes and visual outcome after acute primary angle closure.

    Loon SC, Chew PT, Oen FT, Chan YH, Wong HT, Seah SK, Aung T.

    Clin Experiment Ophthalmol. 2005 Oct;33(5):473-7.PMID: 16181271 [PubMed - indexed for MEDLINE]Related articles

    11.

    Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.

    Lam DS, Leung DY, Tham CC, Li FC, Kwong YY, Chiu TY, Fan DS.

    Ophthalmology. 2008 Jul;115(7):1134-40. Epub 2007 Dec 27.PMID: 18164064 [PubMed - indexed for MEDLINE]Related articles

    12.

    Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.

    Konstas AG, Stewart WC, Topouzis F, Tersis I, Holmes KT, Stangos NT.

    Am J Ophthalmol. 2001 Jun;131(6):729-33.PMID: 11384568 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma.

    Oztürk F, Ermiş SS, Inan UU, Aşagidag A, Yaman S.

    J Ocul Pharmacol Ther. 2005 Feb;21(1):68-74.PMID: 15718830 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.

    Vogel R, Crick RP, Mills KB, Reynolds PM, Sass W, Clineschmidt CM, Tipping R.

    Ophthalmology. 1992 Oct;99(10):1505-11.PMID: 1454315 [PubMed - indexed for MEDLINE]Related articles

    15.

    12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.

    Goñi FJ; Brimonidine/Timolol Fixed Combination Study Group.

    Eur J Ophthalmol. 2005 Sep-Oct;15(5):581-90.PMID: 16167288 [PubMed - indexed for MEDLINE]Related articles

    16.

    Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.

    Aung T, Chan YH, Chew PT; EXACT Study Group.

    Ophthalmology. 2005 Feb;112(2):267-71.PMID: 15691562 [PubMed - indexed for MEDLINE]Related articles

    17.

    Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy.

    Ang LP, Aung T, Chew PT.

    Ophthalmology. 2000 Nov;107(11):2092-6.PMID: 11054339 [PubMed - indexed for MEDLINE]Related articles

    18.

    Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease.

    Ang LP, Aung T, Chua WH, Yip LW, Chew PT.

    Ophthalmology. 2004 Sep;111(9):1636-40.PMID: 15350315 [PubMed - indexed for MEDLINE]Related articles

    19.

    Analysis of progressive change in automated visual fields in glaucoma.

    Smith SD, Katz J, Quigley HA.

    Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1419-28.PMID: 8641844 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

    Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM, Whitcup SM.

    Arch Ophthalmol. 2006 Sep;124(9):1230-8.PMID: 16966616 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity